WHO. Global tuberculosis report 2021. Geneva: World Health Organization. 2021. Licence: CC BY-NC-SA 3.0 IGO. 2021. Available from: https://www.who.int/publications-detail-redirect/9789240037021. Cited 10 Feb 2023.
WHO. Global tuberculosis report 2023. Geneva: World Health Organization. 2023. Licence: CC BY-NC-SA 3.0 IGO. 2023. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023. Cited 7 Jan 2024.
World Health Organisation. Systematic screening for active tuberculosis: principles and recommendations. World Health Organization; 2013. https://books.google.co.za/books?id=g7EXDAAAQBAJ
Uplekar M, Creswell J, Ottmani SE, Weil D, Sahu S, Lönnroth K. Programmatic approaches to screening for active tuberculosis. Int J Tuberc Lung Dis. 2013;17(10):1248–56.
World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. World Health Organization. 2013. xv, 79 p. Available from: https://apps.who.int/iris/handle/10665/112472. Cited 10 Feb 2023.
National Tuberculosis Management Guidelines. 2014. Available from: https://www.tbonline.info/media/uploads/documents/national_tuberculosis_management_guidelines_%282014%29.pdf. Cited 10 Feb 2023.
Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N et al. An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV. N Engl J Med. 2010;362(8):707–16. Available from: https://doi.org/10.1056/NEJMoa0907488. Cited 12 Apr 2021.
Hanifa Y, Fielding KL, Chihota VN, Adonis L, Charalambous S, Foster N et al. A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa. PLOS ONE. 2017;12(8):e0181519. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181519. Cited 10 Feb 2023.
Hanifa Y, Silva ST, Karstaedt A, Sahid F, Charalambous S, Chihota VN et al. What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations? Int J Tuberc Lung Dis. 2019;23(2):157. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394279/. Cited 10 Feb 2023.
Hanifa Y, Fielding KL, Chihota VN, Adonis L, Charalambous S, Foster N et al. The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result. Gates Open Research; 2022 . Available from: https://gatesopenresearch.org/articles/2-22. Cited 10 Feb 2023.
NICD. Weekly Influenza and Respiratory Syncytial Surveillance Report. NICD. 2013. Available from: https://www.nicd.ac.za/publications__trashed/weekly-influenza-and-respiratory-syncytial-surveillance-report/. Cited 11 Feb 2023.
Brennan A, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L et al. Prevalence of TB symptoms, diagnosis and treatment among people living with HIV (PLHIV) not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial. BMJ Open. 2020;10(9):e035794. Available from: https://bmjopen.bmj.com/content/10/9/e035794. Cited 21 Feb 2023.
Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R et al. Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic. Clin Infect Dis. 2012;55(12):1698–706. Available from: https://doi.org/10.1093/cid/cis775. Cited 21 Feb 2023.
Rie AV, Clouse K, Hanrahan C, Selibas K, Sanne I, Williams S et al. High Uptake of Systematic HIV Counseling and Testing and TB Symptom Screening at a Primary Care Clinic in South Africa. PLOS ONE. 2014;9(9):e105428. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0105428. Cited 21 Feb 2023.
Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23(13):1717. Available from: https://journals.lww.com/aidsonline/abstract/2009/08240/short_term_and_long_term_risk_of_tuberculosis.11.aspx. Cited 27 Jul 2025.
Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29(15):1987. Available from: https://journals.lww.com/aidsonline/fulltext/2015/09240/Prevalence_of_tuberculosis_in_post_mortem_studies.12.aspx. Cited 27 Jul 2025.
Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis. 2006;6(8):483–95. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473309906705497/abstract. Cited 27 Jul 2025.
Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White ACJ et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399. Available from: https://journals.lww.com/aidsonline/abstract/2005/03040/incidence_and_risk_factors_for_immune.5.aspx. Cited 27 Jul 2025.
Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN et al. Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa. PLOS ONE. 2013;8(1):e55305. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055305. Cited 27 Jul 2025.
Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516–23. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473309908701841/abstract. Cited 27 Jul 2025.
Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G, Tuberculosis, Co-Infection HIV. PLOS Pathog. 2012;8(2):e1002464. Available from: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002464. Cited 27 Jul 2025.
Getahun H, Harrington M, O’Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet. 2007;369(9578):2042–9. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60284-0/abstract?is=. Cited 27 Jul 2025.
O’Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Robert Horsburgh C. J. Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection. Emerg Infect Dis. 2013;19(3):416. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3647656/. Cited 27 Jul 2025.
Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of Tuberculosis From Exposure to Tobacco Smoke: A Systematic Review and Meta-analysis. Arch Intern Med. 2007;167(4):335–42. Available from: https://doi.org/10.1001/archinte.167.4.335. Cited 27 Jul 2025.
Shargie EB. Trends, challenges and opportunities in tuberculosis control in rural Ethiopia. 2006; Available from: https://www.researchgate.net/profile/Estifanos-Shargie/publication/255590195_Trends_challenges_and_opportunities_in_tuberculosis_control_in_rural_Ethiopia/links/59034b2a4585152d2e92e606/Trends-challenges-and-opportunities-in-tuberculosis-control-in-rural-Ethiopia.pdf. Cited 27 Jul 2025.
Horton KC, Sumner T, Houben RMGJ, Corbett EL, White RG. A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden. Am J Epidemiol. 2018;187(11):2431–8. Available from: https://doi.org/10.1093/aje/kwy131. Cited 27 Jul 2025.
Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis. PLOS Med. 2011;8(7):e1001063. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001063. Cited 27 Jul 2025.
Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies. PLOS Med. 2011;8(1):e1000391. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000391. Cited 21 Feb 2023.
Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies. PLOS Med. 2011;8(1):e1000391. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000391. Cited 27 July 2025.
Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant AD et al. Undiagnosed Tuberculosis Among HIV Clinic Attendees: Association With Antiretroviral Therapy and Implications for Intensified Case Finding, Isoniazid Preventive Therapy, and Infection Control. JAIDS J Acquir Immune Defic Syndr. 2012;60(2):e22. Available from: https://journals.lww.com/jaids/fulltext/2012/06010/Undiagnosed_Tuberculosis_Among_HIV_Clinic.11.aspx. Cited 27 Jul 2025.
Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2017;17(12):1285–92. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30488-7/abstract. Cited 27 Jul 2025.
Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA et al. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS. 2012;26(8):987. Available from: https://journals.lww.com/aidsonline/abstract/2012/05150/the_cost_effectiveness_of_routine_tuberculosis.10.aspx. Cited 27 Jul 2025.
Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D et al. Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis. PLOS Med. 2012;9(7):e1001270. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001270. Cited 12 Apr 2021.
Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R et al. Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic. Clin Infect Dis. 2012;55(12):1698–706. Available from: https://doi.org/10.1093/cid/cis775. Cited 25 Jul 2021.
Khan FA, Verkuijl S, Parrish A, Chikwava F, Ntumy R, El-Sadr W et al. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS Lond Engl. 2014;28(10):1463–72. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116236/. Cited 25 Jul 2021.
Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2022;22(4):507–18. Available from: https://www.thelancet.com/article/S1473-3099(21)00387-X/fulltext. Cited 27 Jul 2025.
Cohen C, Kleynhans J, Moyes J, McMorrow ML, Treurnicht FK, Hellferscee O, et al. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017–18 (PHIRST): a population cohort study. Lancet Glob Health. 2021;9(6):e863-74. Available from: https://www.sciencedirect.com/science/article/pii/S2214109X21001418. Cited 25 Jul 2021.
Tedijanto C, Hermans S, Cobelens F, Wood R, Andrews JR. Drivers of seasonal variation in tuberculosis incidence: insights from a systematic review and mathematical model. Epidemiol Camb Mass. 2018;29(6):857–66. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167146/. Cited 25 Jul 2021.
The South African Antiretroviral Treatment Guidelines. Final 25 March 2013 corrected. Available from: https://sahivsoc.org/Files/2013%20ART%20Treatment%20Guidelines%20Final%2025%20March%202013%20corrected.pdf. Cited 21 Feb 2023.
NDoD. National Consolidated Guidelines for the Management of HIV and PMTCT. 2020. TB HIV Informational Systems Support Portal. 2020. Available from: https://www.tbhivinfosys.org.za/doc/national-consolidated-guidelines-for-the-management-of-hiv-and-pmtct-2020/. Cited 21 Feb 2023.
HERO. 2022. Does differentiated service delivery for HIV treatment change healthcare providers workload? Provider views from Malawi, South Africa, and Zambia. Available from: https://www.heroza.org/wp-content/uploads/2022/07/Phiri-Providers-Workload_AIDS-2022-Abstract-Submission_Bevis.pdf. Cited 21 Feb 2023.
Huber A, Pascoe S, Nichols B, Long L, Kuchukhidze S, Phiri B, et al. Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis. Glob Health Sci Pract. 2021;9(2):296–307. Available from: https://www.ghspjournal.org/content/9/2/296. Cited 21 Feb 2023.